Endocrine disruptors, nanomaterials, CMR substances, PFAS and fragrance allergens are creating increasingly complex ingredient-safety questions. This session will examine how evolving scientific scrutiny and regulatory developments influence evidence needs, safety assessment and formulation decisions, with a focus on distinguishing established requirements from areas where uncertainty remains.